NAD Augmentation in Diabetes Kidney Disease

Abroad (travel likely)RecruitingPHASE2

Conditions

Type2diabetes · Diabetic Kidney Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Brigham and Women's Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (Nancy K Latham, PhD) · nklatham@bwh.harvard.edu · 6179999195
Contact: Principal Investigator (Shalender Bhasin, MB BS)
Nancy Latham, PhD (Sub-investigator)

Study leads

Shalender Bhasin, MD
Principal Investigator
Brigham and Women's Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Evaluation of Fuling Yunhua Granules and Dihuang Baoyuan Granules in Drug Naive Type 2 Diabetes Patients

Diabetes Mellitus, Type 2 · Diabetes · Type2diabetes

Abroad (travel likely)RecruitingPHASE2

Beijing, China

Type 2 Diabetes and Blood Brain Barrier Improvement

Type2diabetes

Abroad (travel likely)RecruitingEARLY_PHASE1

Los Angeles, United States

Ketones, SGLT2, HFrEF

Type2diabetes · Heart Failure With Reduced Ejection Fraction

Abroad (travel likely)RecruitingEARLY_PHASE1

San Antonio, United States

The Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric Restriction

Type2diabetes

Abroad (travel likely)RecruitingPHASE2

Rochester, United States